| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | sumatriptan |
| Formulation | 3mg/0.5ml, 6mg/0.5ml solution for injection |
| Reference number | 2581 |
| Indication | For the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache. Sumatriptan Injection should only be used where there is a clear diagnosis of migraine or cluster headache |
| Company | Sun Pharmaceutical Industries Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 23/10/2014 |